Valuation check: CLNNW's profit margin is -20059.9%, below the Healthcare sector average of 13.71%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for CLNNW is -20059.9% as of June 2026. That compares with -10386.36% in the prior-year period — down 93.1% year over year. That is below the Healthcare sector average of 13.71%. Investors often review this figure alongside Clene- Warrants (30/12/2025)'s historical trend and sector peers before judging valuation or financial health.
Over the past year, CLNNW's profit margin moved from -10386.36% to -20059.9% — a 93.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Clene- Warrants (30/12/2025)'s valuation or profitability profile.
Against Healthcare companies, CLNNW currently prints -20059.9% for profit margin, while the sector average sits near 13.71%. That is roughly 146406.8% below the sector mean. Large gaps often invite a closer look at Clene- Warrants (30/12/2025)'s growth, margins, and balance sheet.
Profit Margin shows how effectively Clene- Warrants (30/12/2025) converts resources into returns. At -20059.9%, CLNNW may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -10386.36% in the prior-year period — down 93.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting CLNNW's profit margin (-20059.9%), review year-over-year change from -10386.36%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.